GetPortalImpactFactorByIdResp(projectId=1, id=f67913106, cover=https://img.medsci.cn/images/journal/cover/2021/wwk_202109271314373520.jpg, fullname=Cancer Biology & Medicine, abbr=CANCER BIOL MED, pyear=暂无数据, frequence=Quarterly, articleNumbers=571, citedSelf2015=2.5, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.4月, reviewFee=null, pageFee=1500.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2095-3941, greenSci=https://www.greensci.net/search?kw=2095-3941, scijournal=https://www.scijournal.org/impact-factor-of-CANCER-BIOL-MED.shtml, medsciHotlightString=null, medsciHotlightRealtime=9.355, medsciHotlight=14.765, medsciHotlight5year=10.8995, citescore=0.0, hIndex=42, impactFactor=5.5, orgnization=Chinese Anticancer Association, orgnizationUrl=http://cancerbiomed.org, country=China, countryCn=中国大陆, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded|MedSci, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=http://cancerbiomed.org/index.php/cocr, websiteHits=7435, guideForAuthor=http://www.cancerbiomed.org/index.php/cocr/information/authors, guideForAuthorHits=1014, submitWebsite=https://mc03.manuscriptcentral.com/cbm, submitWebsiteHits=6569, content=<p class="p0" style="margin: 1em 0px; user-select: text !important;">Cancer Biology & Medicine为季刊，国内外公开发行，由中国科学技术协会主管、中国抗癌协会主办，主编为我国著名肿瘤学专家郝希山院士。作为中国抗癌协会国内外学术交流的重要媒介，以肿瘤临床医师、基础研究人员、相关交叉学科专业人员及医学生为读者对象，向国际学术界展示中国肿瘤防治研究成果，向国内肿瘤学相关专业人员介绍全球肿瘤学前沿进展。刊登稿件范畴：肿瘤表观遗传学、肿瘤干细胞生物学、分子与临床免疫学、肿瘤预防与流行病学、肿瘤标志物、肿瘤影像学、肿瘤临床试验、肿瘤靶向治疗、肿瘤生物治疗、肿瘤个体化医学与多学科综合治疗。设有述评、综述、论著、临床指南、会议报道、病例报告、读者来信等栏目。</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">Cancer Biology & Medicine is a peer-reviewed open-access journal published by the <a style="user-select: text !important;" title="Chinese Anti-cancer Association (CACA)" href="http://www.caca.org.cn/english/">Chinese Anti-cancer Association (CACA)</a>, which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Cancer genetics</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Cancer and stem cell biology</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Molecular and clinical immunology</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Cancer prevention and epidemiology</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Cancer biomarkers</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Radiation oncology</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Oncology clinical trials</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Mechanisms of drug sensitivity and resistance</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Targeted therapy and immunotherapy</p> <p class="p0" style="margin: 1em 0px; user-select: text !important;">● Multidisciplinary treatment and personalized medicine</p>, totalCites=3145, brief=CANCER BIOL MED杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=医学" >医学</a></strong>”子行业的顶级杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=CANCER BIOL MED在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=f67913106'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=7), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=2), ImpactFactorTagDto(id=5543, tagName=肿瘤转化医学, createdHits=1), ImpactFactorTagDto(id=2298, tagName=流行病学, createdHits=1), ImpactFactorTagDto(id=1559, tagName=肿瘤学, createdHits=1), ImpactFactorTagDto(id=285, tagName=乳腺癌, createdHits=1), ImpactFactorTagDto(id=41694, tagName=肿瘤机制, createdHits=1), ImpactFactorTagDto(id=108139, tagName=肿瘤血管发生, createdHits=1), ImpactFactorTagDto(id=41156, tagName=肿瘤基础研究, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.73), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.06), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.7), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=13.759), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=18.566), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=13.711), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=11.035), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=9.355)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=39/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=36/191)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2095-3941[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Cancer Biology & Medicine[ta], article_number=109, article_number_cn=96, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)